Loading organizations...
§ Private Profile · Shenzhen, Guangdong, China
Medical device company developing pan-vascular interventional surgical robots for hospitals, reducing radiation exposure.
Aibo Medical Robot is a Shenzhen, China-based medical device manufacturer that develops pan-vascular interventional surgical robots designed to assist physicians in performing complex endovascular procedures. The enterprise supplies these robotic surgical systems and proprietary consumables directly to healthcare institutions, specifically targeting cardiovascular, neurovascular, and peripheral vascular surgical departments to improve operative precision and reduce radiation exposure. To scale its operations, the business raised over 120 million RMB, equivalent to approximately $16 million, in a November 2021 Pre-A venture funding round led by Qiming Venture Partners and Shenzhen Capital Group. Following this investment, the firm's core vascular interventional robot received approval to enter the special review procedure for innovative medical devices administered by China's National Medical Products Administration. Aibo Medical Robot was officially established in 2020 by founder and chief executive officer Guo Jian.
Aibo Medical Robot has raised $33.0M across 2 funding rounds.
Aibo Medical Robot has raised $33.0M in total across 2 funding rounds.
Aibo Medical Robot has raised $33.0M in total across 2 funding rounds.
Aibo Medical Robot's investors include Guozhong Capital, Xiaodong Jiang, CDH Investments.
Aibo Medical Robot has raised $33.0M across 2 funding rounds. Most recently, it raised $14.1M Series A in June 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2023 | $14.1M Series A | Guozhong Capital | Xiaodong Jiang | Announced |
| Mar 18, 2022 | $18.9M Seed Plus | CDH Investments | — | Announced |